Abiopharma

🔍 Martell Frank (Executive)

Company: SmartRent, Inc. (SMRT)

Report Date: 2026-06-30

Detailed Transactions and Holdings:

• Acquired 450,000 shares of Class A Common Stock (Direct)
  Date: 2026-06-30 | Code: M | equity_swap_involved: false | shares_owned_after: 450,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 223,110 shares of Class A Common Stock at $1.22 per share (Direct)
  Date: 2026-06-30 | Code: F | equity_swap_involved: false | shares_owned_after: 226,890.00 | transaction_form_type: 4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-30 | Code: H | nature_of_ownership: Frank D. and Donna M. Martell Family Trust | shares_owned_after: 3,345,196.00 | Footnotes: F2
• Sold 450,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-30 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's Class A Common Stock, par value $0.001 per share.
• F2: The number of shares held reflects the transfer of 119,670 shares of Common Stock from the Reporting Person to the Frank D. and Donna M. Martell Family Trust, under agreement dated December 10, 2025, of which the Reporting Person and his spouse are co-trustees.
• F3: On June 16, 2025, the reporting person was granted 1,800,000 Restricted Stock Units, vesting in four substantially equal quarterly installments, such that 100% of the RSUs subject to the CEO Grant will be vested as of June 30, 2026.